Human β-defensins and psoriasin/S100A7 expression in salivary glands: Anti-oncogenic molecules for potential therapeutic approaches

BioDrugs

Volumn 26, Issue 1, 2012, Pages 33-42

  Kesting, Marco R ^a   Stoeckelhuber, Mechthild ^a   Kuppek, Alexandra ^a   Hasler, Rafael ^a   Rohleder, Nils ^a   Wolff, Klaus Dietrich ^a   Nieberler, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biological tumour marker targets; Biomarkers; Defensin modulators; Salivary gland cancer.

Indexed keywords

BETA DEFENSIN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; PSORIASIN; RNA 18S; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PAROTID GLAND TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND; SALIVARY GLAND TUMOR; SUBMANDIBULAR GLAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-DEFENSINS; CASE-CONTROL STUDIES; CHILD; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; S100 PROTEINS; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855696047     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11597570-000000000-00000     Document Type: Article

References (64)

1. Diamond G, Zasloff M, Eck H, et al. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S A 1991 May 1; 88 (9): 3952-6 (Pubitemid 21916742)
2. Sun CQ, Arnold R, Fernandez-Golarz C, et al. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006 Sep 1; 66 (17): 8542-9 (Pubitemid 44449167)
3. Donald CD, Sun CQ, Lim SD, et al. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 2003 Apr; 83 (4): 501-5 (Pubitemid 36457704)
4. Pantelis A, Wenghoefer M, Haas S, et al. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2009 Jun; 45 (6): 526-30
5. Stoeckelhuber M, Matthias C, Andratschke M, et al. Human ceruminous gland: ultrastructure and histochemical analysis of antimicrobial and cytoskeletal components. Anat Rec A Discov Mol Cell Evol Biol 2006 Aug; 288 (8): 877-84 (Pubitemid 44222844)
6. Yamaguchi Y, Nagase T, Makita R, et al. Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol 2002 Sep 1; 169 (5): 2516-23 (Pubitemid 34920996)
7. Beckloff N, Diamond G. Computational analysis suggests beta-defensins are processed to mature peptides by signal peptidase. Protein Pept Lett 2008; 15 (5): 536-40 (Pubitemid 351872475)
8. Droin N, Hendra JB, Ducoroy P, et al. Human defensins as cancer biomarkers and antitumour molecules. J Proteomics 2009 Aug 20; 72 (6): 918-27
9. Zhu BD, Feng Y, Huang N, et al. Mycobacterium bovis bacille Calmette- Guerin (BCG) enhances human beta-defensin-1 gene transcription in human pulmonary gland epithelial cells. Acta Pharmacol Sin 2003 Sep; 24 (9): 907-12
10. Abiko Y, Nishimura M, Kaku T. Defensins in saliva and the salivary glands. Med Electron Microsc 2003 Dec; 36 (4): 247-52 (Pubitemid 38145543)
11. Abiko Y, Saitoh M. Salivary defensins and their importance in oral health and disease. Curr Pharm Des 2007; 13 (30): 3065-72 (Pubitemid 350138961)
12. Sahasrabudhe KS, Kimball JR, Morton TH, et al. Expression of the antimicrobial peptide, human beta-defensin 1, in duct cells of minor salivary glands and detection in saliva. J Dent Res 2000 Sep; 79 (9): 1669-74 (Pubitemid 32489432)
13. Froy O. Regulation of mammalian defensin expression by Toll-like receptordependent and independent signalling pathways. Cell Microbiol 2005 Oct; 7 (10): 1387-97 (Pubitemid 41335243)
14. Winter J, Pantelis A, Reich R, et al. Human b-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Invest 2011 Mar; 29 (3): 196-201
15. Boniotto M, Hazbon MH, Jordan WJ, et al. Novel hairpin-shaped primer assay to study the association of the -44 single-nucleotide polymorphism of the DEFB1 gene with early-onset periodontal disease. Clin Diagn Lab Immunol 2004 Jul; 11 (4): 766-9 (Pubitemid 38944002)
16. Vatta S, Boniotto M, Bevilacqua E, et al. Human beta defensin 1 gene: six new variants. Hum Mutat 2000 Jun; 15 (6): 582-3
17. Schnapp D, Reid CJ, Harris A. Localization of expression of human beta defensin-1 in the pancreas and kidney. J Pathol 1998 Sep; 186 (1): 99-103 (Pubitemid 28407494)
18. Bullard RS, Gibson W, Bose SK, et al. Functional analysis of the host defense peptide human beta defensin-1: new insight into its potential role in cancer. Mol Immunol 2008 Feb; 45 (3): 839-48 (Pubitemid 47505263)
19. Shestakova T, Zhuravel E, Bolgova L, et al. Immunohistochemical analysis of beta-defensin-2 expression in human lung tumors. Exp Oncol 2010 Dec; 32 (4): 273-6
20. Kesting MR, Loeffelbein DJ, Hasler RJ, et al. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 2009 Jun; 27 (5): 575-81
21. Nishimura M, Abiko Y, Kusano K, et al. Localization of human beta-defensin 3 mRNA in normal oral epithelium, leukoplakia, and lichen planus: an in situ hybridization study. Med Electron Microsc 2003 Jun; 36 (2): 94-7 (Pubitemid 36903230)
22. Mburu YK, Abe K, Ferris LK, et al. Human {beta}-defensin 3 promotes NF-kappaB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis 2010 Feb; 32 (2): 168-74
23. Madsen P, Rasmussen HH, Leffers H, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein ''psoriasin'' that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991 Oct; 97 (4): 701-12
24. Celis JE, Rasmussen HH, Vorum H, et al. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996 Jun; 155 (6): 2105-12 (Pubitemid 26146716)
25. Al-Haddad S, Zhang Z, Leygue E, et al. Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999 Dec; 155 (6): 2057-66
26. Moubayed N, Weichenthal M, Harder J, et al. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007 Apr; 133 (4): 253-61
27. Morgan MR, Jazayeri M, Ramsay AG, et al. Psoriasin (S100A7) associates with integrin beta6 subunit and is required for avb6-dependent carcinoma cell invasion. Oncogene 2011 Mar; 30 (12): 1422-35
28. Tripathi SC, Matta A, Kaur J, et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One 2010; 5 (8): e11939
29. Kesting MR, Sudhoff H, Hasler RJ, et al. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol 2009 Aug; 45 (8): 731-6
30. Winter J, Pantelis A, Allam JP, et al. High a-defensin and S100A7 expression and missing DOC-1 down-regulation characterize irritation fibromas of the oral cavity and may counteract malignant transformation. J Craniofac Surg 2011 Jan; 22 (1): 100-4
31. Hocwald E, Korkmaz H, Yoo GH, et al. Prognostic factors in major salivary gland cancer. Laryngoscope 2001 Aug; 111 (8): 1434-9 (Pubitemid 32730192)
32. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 2005 Nov; 133 (5): 702-8 (Pubitemid 41586057)
33. Cheung MC, Franzmann E, Sola JE, et al. Acomprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res 2011 Nov; 171 (1): 151-8
34. Surakanti SG, Agulnik M. Salivary gland malignancies: The role for chemotherapy and molecular targeted agents. Semin Oncol 2008 Jun; 35 (3): 309-19 (Pubitemid 351787699)
35. Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch 2002 May; 440 (5): 536-42 (Pubitemid 34591738)
36. Barnes L, Everson JW, Reichart P. World Health Organization classification of tumours, pathology and genetics of head and neck tumours. Lyon: JARC Press, 2005
37. Lundy FT, Orr DF, Gallagher JR, et al. Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue. Oral Oncol 2004 Feb; 40 (2): 139-44 (Pubitemid 38030356)
38. Pazgier M, Hoover DM, Yang D, et al. Human b-defensins. Cell Mol Life Sci 2006 Jun; 63 (11): 1294-313
39. Joly S, Compton LM, Pujol C, et al. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol 2009 Oct; 24 (5): 353-60
40. Roesch-Ely M, Nees M, Karsai S, et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 2007 Jan 4; 26 (1): 54-64 (Pubitemid 46067331)
41. Escher N, Spies-Weisshart B, Kaatz M, et al. Identification of HNP3 as a tumour marker in CD4+ and CD4- lymphocytes of patients with cutaneous T-cell lymphoma. Eur J Cancer 2006 Jan; 42 (2): 249-55 (Pubitemid 43083497)
42. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005 Jun; 6 (6): 551-7 (Pubitemid 41710724)
43. Wenghoefer M, Pantelis A, Dommisch H, et al. Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer 2008; 8: 290
44. Wenghoefer M, Pantelis A, Dommisch H, et al. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 2008 Jul; 37 (7): 660-3 (Pubitemid 351905974)
45. Bose SK, Gibson W, Bullard RS, et al. PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. Mol Immunol 2009 Mar; 46 (6): 1140-8
46. Jaehne M, Roeser K, Jaekel T, et al. Clinical and immunohistologic typing of salivary duct carcinoma: A report of 50 cases. Cancer 2005 Jun 15; 103 (12): 2526-33 (Pubitemid 40800531)
47. Zhuravel E, Shestakova T, Efanova O, et al. Human b-defensin-2 controls cell cycle in malignant epithelial cells: in vitro study. Exp Oncol 2011 Sep; 33 (3): 114-20
48. Sorensen OE, Thapa DR, Rosenthal A, et al. Differential regulation of b-defensin expression in human skin by microbial stimuli. J Immunol 2005 Apr 15; 174 (8): 4870-9
49. Sorensen OE, Thapa DR, Roupe KM, et al. Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 2006 Jul; 116 (7): 1878-85 (Pubitemid 44033312)
50. Voss E, Wehkamp J, Wehkamp K, et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 2006 Jan 27; 281 (4): 2005-11 (Pubitemid 43845788)
51. Kusmartsev S, Gabrilovich DI. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 2002 Aug; 51 (6): 293-8 (Pubitemid 34743981)
52. Wang J, Xi L, Hunt JL, et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 2004 Mar 1; 64 (5): 1861-6 (Pubitemid 38428712)
53. Mburu YK, Abe K, Ferris LK, et al. Human b-defensin 3 promotes NF-kBmediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis 2011 Feb; 32 (2): 168-74
54. Melle C, Ernst G, Schimmel B, et al. Discovery and identification of a-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology 2005 Jul; 129 (1): 66-73 (Pubitemid 41002043)
55. Albrethsen J, Moller CH, Olsen J, et al. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer. Eur J Cancer 2006 Nov; 42 (17): 3057-64 (Pubitemid 44679822)
56. Ghavami S, Asoodeh A, Klonisch T, et al. Brevinin-2R (1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomalmitochondrial death pathway. J Cell Mol Med 2008 Jun; 12 (3): 1005-22 (Pubitemid 351718078)
57. Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 2006 Aug; 15 (8): 933-46 (Pubitemid 44177845)
58. Barker E, Reisfeld RA. A mechanism for neutrophil-mediated lysis of human neuroblastoma cells. Cancer Res 1993 Jan 15; 53 (2): 362-7 (Pubitemid 23031850)
59. McKeown ST, Lundy FT, Nelson J, et al. The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. Oral Oncol 2006 Aug; 42 (7): 685-90 (Pubitemid 44094234)
60. Hubert P, Herman L, Maillard C, et al. Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo. FASEB J 2007 Sep; 21 (11): 2765-75 (Pubitemid 47372744)
61. Biragyn A. Defensins: non-antibiotic use for vaccine development. Curr Protein Pept Sci 2005 Feb; 6 (1): 53-60 (Pubitemid 40259801)
62. Tani K, Murphy WJ, Chertov O, et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 2000 May; 12 (5): 691-700 (Pubitemid 30248902)
63. BiragynA,Ruffini PA, LeiferCA, et al. Toll-like receptor 4-dependent activation of dendritic cells by b-defensin 2. Science 2002 Nov 1; 298 (5595): 1025-9 (Pubitemid 35247310)
64. Biragyn A, Coscia M, Nagashima K, et al. Murine b-defensin 2 promotes TLR-4/MyD88-mediated and NF-kB-dependent atypical death of APCs via activation of TNFR2. J Leukoc Biol 2008 Apr; 83 (4): 998-1008 (Pubitemid 351959881)